Multiple Sclerosis Clinical Trial
Official title:
Effects of a Game-based Virtual Reality Video Capture Training Program Plus Occupational Therapy on Manual Dexterity in Patients With Multiple Sclerosis: a Randomizaed Controlled Trial
Introduction. Multiple sclerosis (MS) is the most common neurological disease causing
disability in young adults. Neurorehabilitation is a fundamental aspect in the treatment
approach for MS, in which new technologies have gained popularity, especially the use of
virtual reality (VR), thanks to the therapeutic possibilities offered for patients with MS
presenting cognitive, sensitive and motor dysfunctions.
Aim. To analyze and compare an occupational therapy intervention (OT) compared with OT + VR
(OT+VR) on the manual dexterity of patients with MS.
Material and methods. 26 patients will be recruited. The control group (n=8) will recieve 20
conventional OT sessions distributed in two sessions per week. The experimental group OT+VR
(n=8) will recieve 20 sessions of VR interventions, twice weekly and lasting 30 minutes,
consisting of VR games accessed via the online webpage motiongamingconsole.com, including
Flip Out, Air Hockey, Partículas, Dunkit, Cuenta peces and Robo Maro, in addition to the
conventional OT sessions. Pre and post-intervention assessments will be based on the Purdue
Pegboard Test, the Jebsen Taylor Hand Function Test and the Grooved Pegboard Test.
Multiple sclerosis (MS) is a chronic inflammatory demyelinating illness of the central
nervous system (CNS) of unknown etiology and a multifactorial origin. Currently, MS
represents the most common neurological illness that causes disability among young adults in
Europe and North America.
The symptoms depend on the areas of the CNS that are injured, with considerable clinical
variability between patients, depending on the level of severity and the duration of the
disease. Among the most common symptoms, patients exhibit fatigue, visual disorders,
problems affecting balance and coordination, sensitivity disorders, spasticity, cognitive
and emotional disorders, speech disorders, problems affecting the bladder and intestines, as
well as sexual related dysfunction.
Different disease courses exist for MS, according to the appearance of symptoms, such as
relapsing-remitting MS, primary progressive MS, secondary-progressive MS and
progressive-recurrent MS. Relapsing-remitting MS is the most common form of MS.
The symptoms appear in the form of relapses, which are of a variable duration and which vary
from one episode to the other, according to the affected area in the CNS. After the
flare-ups, symptoms subside and usually disappear completely, although there may be
neurological aftereffects. In primary-progressive MS, a progressive clinical deterioration
occurs, without relapses, from the onset of the illness. This type of MS is suffered by 12%
of people with MS. In secondary-progressive MS, patients initially present a
relapsing-remitting course, however, over time, they develop a progressive clinical
deterioration without experiencing distinctive relapses. Progressive-recurrent MS, is the
least common type of illness.
Two fundamental and complementary aspects exist in the treatment of MS: pharmacological and
rehabilitation treatments. Over recent years, a substantial change has occurred in the
approach to MS, thanks to the appearance of new drugs aimed at modifying the progression of
the disease. However, these drugs would be more effective if they were complemented by a
good rehabilitation program. With regards rehabilitation, a symptomatic treatment of MS is
performed in order to improve the quality of life and functional independence, with the main
therapeutic demands being the alterations of postural control and the performance of
activities of daily living. Occupational therapy (OT) assesses the capacities and physical,
psychological, sensory and social problems of the individual with MS, in order to enable the
person to achieve the greatest possible level of independence in their daily living and/or
to facilitate the adaptation to their disability. At times, rehabilitation treatments for
patients with MS can be very lengthy and systematic, leading to patients that lose
motivation and compliance. As a result, in recent years, new intervention strategies have
been introduced, such as virtual reality (VR), thanks to VR motion capture technology
without the need of using any device or controller. Here, patient motivation is promoted via
novel approaches based on practicing functional tasks in virtual surroundings, which provide
feedback to the patient concerning results, and are based on the repetition of activities of
daily living (ADLs). The development of these technologies has provided rehabilitation
professionals with the ability to expand the care of patients with MS as a complement to
their rehabilitation program, achieving a higher treatment intensity at a sustainable cost.
However, there are few studies on the effects that VR has on the manual dexterity of
patients with MS.
Therefore, the objective of the present study was to analyze the effects of an OT
intervention combined with VR on manual skills, compared with conventional OT approaches in
people with MS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |